ESC 365 - Novel drugs in acute heart failure: hurdles, hype and hope

HFA Premium Access

Novel drugs in acute heart failure: hurdles, hype and hope

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Acute heart failure (therapy)

Session type: Symposium

Date: 29 April 2017

Time: 14:45 - 16:15

Session

5 presentations in this session

Serelaxin.

Speaker: Professor M. Metra (Brescia, IT)

HNO Donors.

Speaker: Professor J. Butler (Jackson, US)

Omecamtiv mecarbil

Speaker: Professor J. Teerlink (San Francisco, US)

Elamipretide.

Speaker: Professor H. Sabbah (Detroit, US)

Vericiquat.

Speaker: Professor B. Pieske (Berlin, DE)

5 speakers from this session

Professor Marco Metra

University of Brescia, Brescia (Italy)

81 presentations

12 followers

Professor Javed Butler

University of Mississippi, Jackson (United States of America)

65 presentations

3 followers

Professor John R Teerlink

San Francisco Veterans Affairs Medical Center, San Francisco (United States of America)

18 presentations

0 follower

Professor Hani Sabbah

Henry Ford Hospital, Detroit (United States of America)

2 presentations

0 follower

Professor Burkert Pieske

Charite - Campus Virchow-Klinikum (CVK) and German Heart Center, Berlin (Germany)

49 presentations

0 follower

This platform is supported by